摘要

This article describes the continuous flow synthesis of 6-methoxy-8-(4-methyl-1,4-diazepan-1-yl)-N-(4-morpholinophenyl)-4-oxo-1,4-dihydroquinoline-2-carboxamide, a potent 5HT(1B) antagonist developed by AstraZeneca.

  • 出版日期2010-3